Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of acute hemeolytic anaemia (AHA)

S. A. Dar; M. Wahid; S. Haque; S. S. Almalki; N. Akhter

doi:10.26355/eurrev_202008_22473

Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of acute hemeolytic anaemia (AHA)

S. A. Dar
, M. Wahid
, S. Haque
, S. S. Almalki
, N. Akhter

Jazan University
Al Baha University

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	7923-7924
Number of pages	2
Journal	European Review for Medical and Pharmacological Sciences
Volume	24
Issue number	15
DOIs	https://doi.org/10.26355/eurrev_202008_22473
State	Published - 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.26355/eurrev_202008_22473

Cite this

@article{1c218080942949129c3bf843ac29a063,

title = "Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of acute hemeolytic anaemia (AHA)",

author = "Dar, \{S. A.\} and M. Wahid and S. Haque and Almalki, \{S. S.\} and N. Akhter",

year = "2020",

doi = "10.26355/eurrev\_202008\_22473",

language = "English",

volume = "24",

pages = "7923--7924",

journal = "European Review for Medical and Pharmacological Sciences",

issn = "1128-3602",

publisher = "Verduci Editore s.r.l",

number = "15",

}

TY - JOUR

T1 - Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of acute hemeolytic anaemia (AHA)

AU - Dar, S. A.

AU - Wahid, M.

AU - Haque, S.

AU - Almalki, S. S.

AU - Akhter, N.

PY - 2020

Y1 - 2020

UR - https://www.scopus.com/pages/publications/85089302174

U2 - 10.26355/eurrev_202008_22473

DO - 10.26355/eurrev_202008_22473

M3 - Letter

C2 - 32767316

AN - SCOPUS:85089302174

SN - 1128-3602

VL - 24

SP - 7923

EP - 7924

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

IS - 15

ER -

Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of acute hemeolytic anaemia (AHA)

UN SDGs

Access to Document

Other files and links

Cite this